Applications of certain traditional and new polymers, including bioabsorbable/ biodegradable ones, in the development of biomedical devices and controlled drug/bioactive-agent delivery have become a key catalyst in realizing recent developments in biotechnology, pharmaceutical, medical, and bioengineering research. Poly-Med commenced its R&D operation in Pendleton, South Carolina, in 1995 to propel the use of polymers into new and often novel pharmaceutical and biomedical applications. The basic tenets of Poly-Med's R&D strategy are focused on proprietary materials, novel processes, and advanced systems design. Poly-Med values its proprietary technology and explores vigorously any useful adjunct applications beyond those within the scope of its core mission.

Our Mission:
The Company’s core mission is to harness its materials, pharmaceutical and bioengineering know-how and resources to develop proprietary absorbable and non-absorbable polymers and biomaterials and pertinent technologies to design and evaluate product prototypes for licensing to healthcare products and polymer manufacturing partners and to manufacture premium and specialty PMI products for marketing partners.